COMMUNIQUÉS West-GlobeNewswire

Annual Report 2017/18
15/10/2018
Company announcement no.14/2018 For further information, please contact: Head of IR Martin Riise Tel.: +45 5339 2250 dkmari@chr-hansen.com IR Officer Annika Stern Tel.: +45 2399 2382 dkaste@chr-hansen.com FORWARD- [...]
Rule 2.9 Announcement
15/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 October 2018 [...]
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
15/10/2018
Amsterdam, The Netherlands - 15 October 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 22 nd Tranche of EUR 400,000 is issued as a private placement of 40 convertible notes (the " [...]
Santhera Receives Positive Opinion for Orphan Drug Designation in the EU for POL6014 in Cystic Fibrosis
15/10/2018
Pratteln, Switzerland, October 15, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on [...]
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act
15/10/2018
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act HALLE (SAALE), Germany, 15 October 2018 - The management board of Probiodrug AG ("Probiodrug", Euronext: PBD), a clinical [...]
Telix and ANMI Expand PSMA Imaging Partnership
15/10/2018
MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
15/10/2018
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Michael
12/10/2018
Residents and Those Displaced Can Call 855-764-1727 to Access Treatment for Non-Emergency Illnesses PURCHASE, NY, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, is [...]
Terra Tech Corp. Announces Plans to Expand its Cannabis Dispensary Footprint with Purchase of Las Vegas Property
12/10/2018
IRVINE, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, today announced it has purchased a retail [...]
Trevena to Present Phase 3, Open-Label Safety Study of Oliceridine at the American Society of Anesthesiologists Annual Meeting
12/10/2018
CHESTERBROOK, Pa., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) today announced a poster presentation at ANESTHESIOLOGY® 2018, the national conference for the American Society of Anesthesiologists (ASA [...]
A Letter from Emblem’s President & CEO
12/10/2018
TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC, OTCQX: EMMBF ) (" Emblem " or the " Company ") delivers strategic vision to shareholders: With adult-use legalization only days away, I am incredibly [...]
Michael DePerro, MD, Offers Minimally Invasive Gynecomastia Surgery Technique
12/10/2018
This unique approach helps reduce scarring that typically results from the procedure. COLUMBUS, Ohio, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Dr. Michael DePerro , double board-certified plastic surgeon and head of DePerro [...]
NovuHealth Named No. 5 on Minneapolis/St. Paul Business Journal's Fast 50 List for Two Years Running
12/10/2018
Company Is Top Healthcare Firm on List of the 50 Fastest-Growing Private Companies in the Twin Cities, with 230% Growth from 2015-2017 MINNEAPOLIS, Oct. 12, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’ [...]
Innovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation Conference
12/10/2018
BEVERLY, Mass., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide this update on Brilacidin as a novel [...]
RAMSAY GENERALE DE SANTE : supplement to the offer document in respect of the public offer to the shareholders of Capio
12/10/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRIC A. THE OFFER IS NOT BEING MADE TO (AND [...]
RAMSAY GENERALE DE SANTE : complément au document d'offre relatif à l'offre publique d'achat faite aux actionnaires de Capio
12/10/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'EST PAS FAITE [...]
Trident Brands Inc. Entering US Hemp CBD Market with Brain Armor® R3 Supplement
12/10/2018
Brookfield, WI, Oct. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announces that Brain Armor® will launch a line of products that include CBD [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2018
12/10/2018
Communiqué de presse Villepinte, le 12 octobre 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
US Patent Trial & Appeal Board (PTAB) Upholds Silence Patent by Denying First of Five Patent Grant Review Applications Filed by Alnylam
12/10/2018
LONDON, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Silence Therapeutics plc, (AIM:SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious [...]

Pages